BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26374452)

  • 1. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
    Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
    Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
    Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
    Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.
    Heiduschka G; Grah A; Oberndorfer F; Seemann R; Kranz A; Kornek G; Wrba F; Thurnher D; Selzer E
    Strahlenther Onkol; 2014 Sep; 190(9):832-8. PubMed ID: 24715244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
    Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
    Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
    Zhang W; Wang X; Yue K; Liu S; Liu X
    Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
    De-Colle C; Menegakis A; Mönnich D; Welz S; Boeke S; Sipos B; Fend F; Mauz PS; Tinhofer I; Budach V; Abu Jawad J; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Belka C; Ganswindt U; Pigorsch S; Combs SE; Lohaus F; Linge A; Krause M; Baumann M; Zips D;
    Radiother Oncol; 2018 Jan; 126(1):125-131. PubMed ID: 29061496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
    Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
    Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.
    León X; Diez S; García J; Lop J; Sumarroca A; Quer M; Camacho M
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4525-4533. PubMed ID: 27328961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
    Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
    Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
    Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas.
    Oliveira-Neto HH; Silva ET; Leles CR; Mendonça EF; Alencar Rde C; Silva TA; Batista AC
    Tumour Biol; 2008; 29(4):262-71. PubMed ID: 18781098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
    Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
    Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.